Suzanne Mashtoub

412 total citations
34 papers, 312 citations indexed

About

Suzanne Mashtoub is a scholar working on Genetics, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Suzanne Mashtoub has authored 34 papers receiving a total of 312 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Genetics, 9 papers in Molecular Biology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Suzanne Mashtoub's work include Inflammatory Bowel Disease (11 papers), Oral health in cancer treatment (8 papers) and Helicobacter pylori-related gastroenterology studies (6 papers). Suzanne Mashtoub is often cited by papers focused on Inflammatory Bowel Disease (11 papers), Oral health in cancer treatment (8 papers) and Helicobacter pylori-related gastroenterology studies (6 papers). Suzanne Mashtoub collaborates with scholars based in Australia, United States and Israel. Suzanne Mashtoub's co-authors include Gordon S. Howarth, Cuong D. Tran, Kerry A. Lymn, Ker Y. Cheah, Debbie Trinder, Ian C. Lawrance, Christine Feinle‐Bisset, Alexandra L. Whittaker, Roger Yazbeck and Amelia N. Pilichiewicz and has published in prestigious journals such as Gastroenterology, PLoS ONE and Scientific Reports.

In The Last Decade

Suzanne Mashtoub

32 papers receiving 302 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Suzanne Mashtoub Australia	10	107	95	80	60	54	34	312
Maria Emília Rabelo Andrade Brazil	12	105 1.0×	49 0.5×	170 2.1×	21 0.3×	9 0.2×	23	386
Marina Mohd Bakri Malaysia	14	70 0.7×	14 0.1×	141 1.8×	37 0.6×	29 0.5×	32	579
Patrícia Aparecida Vieira de Barros Brazil	10	83 0.8×	51 0.5×	145 1.8×	16 0.3×	8 0.1×	13	362
Thanaporn Rungruang Thailand	13	48 0.4×	27 0.3×	86 1.1×	49 0.8×	29 0.5×	26	461
Luca D. Prisciandaro Australia	7	131 1.2×	60 0.6×	158 2.0×	15 0.3×	8 0.1×	7	356
Tae‐Ho Oh South Korea	11	43 0.4×	18 0.2×	104 1.3×	33 0.6×	37 0.7×	65	419
Priscilla Fernanda Campos Justino Brazil	7	218 2.0×	16 0.2×	125 1.6×	11 0.2×	17 0.3×	9	367
Szu-Han Chen Taiwan	10	29 0.3×	17 0.2×	90 1.1×	43 0.7×	25 0.5×	26	350
Kellym Liboni United States	8	55 0.5×	119 1.3×	190 2.4×	42 0.7×	10 0.2×	9	546
Kareem W. Shehab United States	7	17 0.2×	83 0.9×	207 2.6×	54 0.9×	25 0.5×	14	418

Countries citing papers authored by Suzanne Mashtoub

Since Specialization

Citations

This map shows the geographic impact of Suzanne Mashtoub's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne Mashtoub with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne Mashtoub more than expected).

Fields of papers citing papers by Suzanne Mashtoub

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzanne Mashtoub. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne Mashtoub. The network helps show where Suzanne Mashtoub may publish in the future.

Co-authorship network of co-authors of Suzanne Mashtoub

This figure shows the co-authorship network connecting the top 25 collaborators of Suzanne Mashtoub. A scholar is included among the top collaborators of Suzanne Mashtoub based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzanne Mashtoub. Suzanne Mashtoub is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mashtoub, Suzanne, et al.. (2024). Orally-Administered Emu Oil Reduces Proximal Colonic Crypt Hyperplasia in a Murine Model of Colitis-Associated Colorectal Cancer. Current Developments in Nutrition. 8. 102567–102567.

Mashtoub, Suzanne, Shahid Ullah, Gurmeet Singh, et al.. (2024). Childhood Cancer Incidence and Survival in South Australia and the Northern Territory, 1990–2017, with Emphasis on Indigenous Peoples. Cancers. 16(11). 2057–2057.

Haidari, Homa, Suzanne Mashtoub, Gordon S. Howarth, et al.. (2024). Deferiprone and Gallium-Protoporphyrin Chitogel as an antimicrobial treatment: Preclinical studies demonstrating antimicrobial activity for S. aureus infected cutaneous wounds. International Journal of Biological Macromolecules. 276(Pt 1). 133874–133874. 4 indexed citations

Haidari, Hanif, Suzanne Mashtoub, Gordon S. Howarth, et al.. (2024). Deferiprone-Gallium-Protoporphyrin Chitogel Decreases Pseudomonas aeruginosa Biofilm Infection without Impairing Wound Healing. Materials. 17(4). 793–793. 3 indexed citations

Mashtoub, Suzanne & Gordon S. Howarth. (2023). Emu Oil and zinc monoglycerolate independently reduce disease severity in a rat model of ulcerative colitis. BioMetals. 36(6). 1331–1345. 2 indexed citations

Howarth, Gordon S., et al.. (2021). Neuroimmunological complications arising from chemotherapy‐induced gut toxicity and opioid exposure in female dark agouti rats. Journal of Neuroscience Research. 100(1). 237–250. 2 indexed citations

Howarth, Gordon S., et al.. (2021). Emu Oil and Saireito in combination reduce tumour development and clinical indicators of disease in a mouse model of colitis-associated colorectal cancer. Biomedicine & Pharmacotherapy. 138. 111478–111478. 4 indexed citations

Mashtoub, Suzanne, et al.. (2021). Emu Oil Attenuates Disease Severity and Results in Fewer Large Colonic Tumors in a Mouse Model of Colitis-Associated Colorectal Cancer. Nutrition and Cancer. 74(2). 715–723. 2 indexed citations

Howarth, Gordon S., et al.. (2020). Orally administered emu oil attenuates disease in a mouse model of Crohn’s-like colitis. Experimental Biology and Medicine. 245(18). 1697–1707. 4 indexed citations

10.

Howarth, Gordon S., et al.. (2020). Emu oil and grape seed extract reduce tumour burden and disease parameters in murine colitis-associated colorectal cancer. Carcinogenesis. 42(2). 202–209. 10 indexed citations

11.

Hebart, M. L., et al.. (2020). Affective state determination in a mouse model of colitis-associated colorectal cancer. PLoS ONE. 15(1). e0228413–e0228413. 21 indexed citations

12.

Kopecki, Zlatko, Susan A. Treloar, Suzanne Mashtoub, et al.. (2019). Flightless I exacerbation of inflammatory responses contributes to increased colonic damage in a mouse model of dextran sulphate sodium-induced ulcerative colitis. Scientific Reports. 9(1). 12792–12792. 13 indexed citations

13.

Mashtoub, Suzanne, et al.. (2018). Comparative effects of mistletoe extracts in combination with 5-Fluorouracil on viability of IEC-6 and Caco-2 intestinal epithelial cells. 30(4). 174. 1 indexed citations

14.

Howarth, Gordon S., et al.. (2018). Mo1994 - Emu Oil Improves Clinical Indicators of Disease and Reduces Proximal Colonic Crypt Hyperplasia in a Murine Model of Colitis-Associated Colorectal Cancer. Gastroenterology. 154(6). S–875. 2 indexed citations

15.

Howarth, Gordon S., et al.. (2017). Emu Oil Improves Clinical Indicators of Disease in a Mouse Model of Colitis-Associated Colorectal Cancer. Digestive Diseases and Sciences. 63(1). 135–145. 19 indexed citations

16.

Mashtoub, Suzanne, et al.. (2016). Emu Oil Combined with Lyprinol™ Reduces Small Intestinal Damage in a Rat Model of Chemotherapy-Induced Mucositis. Nutrition and Cancer. 68(7). 1171–1180. 19 indexed citations

17.

Mashtoub, Suzanne, Gordon S. Howarth, Debbie Trinder, & Ian C. Lawrance. (2016). Emu oil promotes bodyweight gain in a mouse model of inflammation-associated colorectal cancer. Journal of Nutrition & Intermediary Metabolism. 4. 14–14. 1 indexed citations

18.

Howarth, Gordon S., et al.. (2015). Intestinal mucositis induced by 5-fluorouracil results in spinal astrocyte expression changes in rats. Journal of Neurochemistry. 1 indexed citations

19.

Mashtoub, Suzanne, et al.. (2015). Oral Nucleotides Only Minimally Improve 5-Fluorouracil-Induced Mucositis in Rats. Nutrition and Cancer. 67(6). 994–1000. 7 indexed citations

20.

Yazbeck, Roger, Kerry A. Lymn, Ker Y. Cheah, et al.. (2009). The herbal extract Iberogast® improves jejunal integrity in rats with 5-Fluorouracil (5-FU)-induced mucositis. Cancer Biology & Therapy. 8(10). 923–929. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact